Concepedia

Author

Jeremy Luke

Nature Technology Corporation (United States)

Also Known As

J M Luke, Jeremy Luke, Jeremy M. Luke

16

Publications

526

Citations

12

H-Index

39

Concepts

All Affiliations

Nature Technology Corporation (United States)
JL

About

Jeremy Luke is an author at Nature Technology Corporation (United States) specializing in medicine, microbiology, and synthetic biology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

10

11

398

2

Engineering

5

5

187

3

Natural Sciences

2

2

35

4

Biomedical Engineering

1

1

38

5

Cell Biology

1

1

25

Jeremy Luke

×

14

Publications

520

Citations

12

H-Index

YearCitations

Improved antibiotic-free DNA vaccine vectors utilizing a novel RNA based plasmid selection system

Jeremy Luke, Aaron E. Carnes, Clague P. Hodgson,

Vaccine

2009

113

Coexpressed RIG-I Agonist Enhances Humoral Immune Response to Influenza Virus DNA Vaccine

Jeremy Luke, Gregory G. Simon, Jonas Söderholm,

Journal of Virology

2010

87

Generic plasmid DNA production platform incorporating low metabolic burden seed‐stock and fed‐batch fermentation processes

James A. Williams, Jeremy Luke, Sarah Langtry,

Biotechnology and Bioengineering

2009

70

Plasmid DNA fermentation strain and process‐specific effects on vector yield, quality, and transgene expression

Aaron E. Carnes, Jeremy Luke, Justin M. Vincent,

Biotechnology and Bioengineering

2010

42

pDNAVACCultra vector family: high throughput intracellular targeting DNA vaccine plasmids

James A. Williams, Jeremy Luke, Lance C. Johnson,

Vaccine

2005

38

Improved antibiotic-free plasmid vector design by incorporation of transient expression enhancers

Jeremy Luke, Justin M. Vincent, Sean X. Du,

Gene Therapy

2010

38

A 5′ Noncoding Exon Containing Engineered Intron Enhances Transgene Expression from Recombinant AAV Vectors <i>in vivo</i>

Jiamiao Lu, James A. Williams, Jeremy Luke,

Human Gene Therapy

2016

25

Plasmid DNA production combining antibiotic‐free selection, inducible high yield fermentation, and novel autolytic purification

Aaron E. Carnes, Clague P. Hodgson, Jeremy Luke,

Biotechnology and Bioengineering

2009

23

Critical design criteria for minimal antibiotic‐free plasmid vectors necessary to combine robust RNA Pol II and Pol III‐mediated eukaryotic expression with high bacterial production yields

Aaron E. Carnes, Jeremy Luke, Justin M. Vincent,

The Journal of Gene Medicine

2010

22

Thermostable tag (TST) protein expression system: Engineering thermotolerant recombinant proteins and vaccines

Jeremy Luke, Aaron E. Carnes, Ping Sun,

Journal of Biotechnology

2010

14

Page 1